| Literature DB >> 28822355 |
Stephen A Wise1, Karen W Phinney2, Susan S-C Tai2, Johanna E Camara2, Gary L Myers3, Ramon Durazo-Arvizu4, Lu Tian5, Andrew N Hoofnagle6, Lorin M Bachmann7, Ian S Young8, Juanita Pettit9, Grahame Caldwell10, Andrew Liu10, Stephen P J Brooks11, Kurtis Sarafin11, Michael Thamm12, Gert B M Mensink12, Markus Busch12, Martina Rabenberg12, Kevin D Cashman13, Mairead Kiely13, Michael Kinsella13, Karen Galvin13, Joy Y Zhang13, Kyungwon Oh14, Sun-Wha Lee15, Chae L Jung15, Lorna Cox16, Gail Goldberg16, Kate Guberg16, Ann Prentice16, Graham D Carter17, Julia Jones17, Patsy M Brannon18, Robyn M Lucas19, Peter M Crump20, Etienne Cavalier21, Joyce Merkel1, Joseph M Betz1, Christopher T Sempos1.
Abstract
The Vitamin D Standardization Program (VDSP) coordinated an interlaboratory study to assess the comparability of measurements of total 25-hydroxyvitamin D [25(OH)D] in human serum, which is the primary marker of vitamin D status. A set of 50 individual donor samples were analyzed by 15 different laboratories representing national nutrition surveys, assay manufacturers, and clinical and/or research laboratories to provide results for total 25(OH)D using both immunoassays (IAs) and LC tandem MS (MS/MS). The results were evaluated relative to bias compared with the target values assigned based on a combination of measurements at Ghent University (Belgium) and the U.S. National Institute of Standards and Technology using reference measurement procedures for the determination of 25(OH)D2 and 25(OH)D3. CV and mean bias for each laboratory and assay platform were assessed and compared with previously established VDSP performance criteria, namely CV ≤ 10% and mean bias ≤ 5%. Nearly all LC-MS/MS results achieved VDSP criteria, whereas only 50% of IAs met the criterion for a ≤10% CV and only three of eight IAs achieved the ≤5% bias. These results establish a benchmark for the evaluation of 25(OH)D assay performance and standardization activities in the future.Entities:
Mesh:
Substances:
Year: 2017 PMID: 28822355 DOI: 10.5740/jaoacint.17-0258
Source DB: PubMed Journal: J AOAC Int ISSN: 1060-3271 Impact factor: 1.913